Pharmacovigilance and Drug Safety Software Market Size, Share, And Growth Report 2032

Pharmacovigilance and Drug Safety Software Market

Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3172 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 200.5 Million USD 370.48 Million 7.06% 2023

Pharmacovigilance and Drug Safety Software Market

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pharmacovigilance and Drug Safety Software Market, 2017-2025 (USD Million)
    • 2.2. Global Pharmacovigilance and Drug Safety Software Market: Snapshot
  •  
  • Chapter 3. Pharmacovigilance and Drug Safety Software Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Pharmacovigilance and Drug Safety Software Market drivers: Impact analysis
      • 3.2.2. The growing rate of clinical trials
      • 3.2.3. An increasing number of CROs
      • 3.2.4. Increasing penetration in emerging countries
    • 3.3. Market Restraints
      • 3.3.1. Global Pharmacovigilance and Drug Safety Software Market restraints: Impact analysis
      • 3.3.2. Stringent Regulations
      • 3.3.3. Concern about drug safety
    • 3.4. Opportunities
      • 3.4.1. Increasing pharma and biotech companies in developing economies
    • 3.5. Porter's Five Forces analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Functionality
      • 3.6.2. Market attractiveness analysis, by Delivery Mode segment
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Pharmacovigilance and Drug Safety Software Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Pharmacovigilance and Drug Safety Software Market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Therapy Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Pharmacovigilance and Drug Safety Software Market - Functionality Analysis
    • 5.1. Global Pharmacovigilance and Drug Safety Software Market: Functionality overview
      • 5.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by Functionality, 2017 and 2025
    • 5.2. ADR Reporting Software
      • 5.2.1. Global ADR Reporting Software Market, 2017-2025 (USD Million)
    • 5.3. Drug Safety Audits Software
      • 5.3.1. Global Drug Safety Audits Software market, 2017-2025 (USD Million)
    • 5.4. Issue Tracking Software
      • 5.4.1. Global Issue Tracking Software market, 2017-2025 (USD Million)
    • 5.5. Fully Integrated Software
      • 5.5.1. Global Fully Integrated Software market, 2017-2025 (USD Million)
  •  
  • Chapter 6. Global Pharmacovigilance and Drug Safety Software Market - Delivery Mode Analysis
    • 6.1. Global Pharmacovigilance and Drug Safety Software Market: Delivery Mode overview
      • 6.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by Delivery Mode, 2017-2025
    • 6.2. On-premises
      • 6.2.1. Global Pharmacovigilance and Drug Safety Software Market for On-premises, 2017-2025 (USD Million)
    • 6.3. On-demand
      • 6.3.1. Global Pharmacovigilance and Drug Safety Software Market for On-demand, 2017-2025 (USD Million)
  •  
  • Chapter 7. Global Pharmacovigilance and Drug Safety Software Market - End-user Analysis
    • 7.1. Global Pharmacovigilance and Drug Safety Software Market: End-user overview
      • 7.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by end-user, 2017and 2025
    • 7.2. Pharma & biotech companies
      • 7.2.1. Global Pharmacovigilance and Drug Safety Software Market for Pharma & biotech companies, 2017-2025 (USD Million)
    • 7.3. Contract Research Organizations (CROS)
      • 7.3.1. Global Pharmacovigilance and Drug Safety Software Market for Contract Research Organizations, 2017-2025 (USD Million)
    • 7.4. Business Process Outsourcing Firms
      • 7.4.1. Global Pharmacovigilance and Drug Safety Software Market for Business Process Outsourcing Firms End-users, 2017-2025 (USD Million)
    • 7.5. Other Pharmacovigilance Service Providers
      • 7.5.1. Global Pharmacovigilance and Drug Safety Software Market for Other End-users, 2017-2025 (USD Million)
  •  
  • Chapter 8. Global Pharmacovigilance and Drug Safety Software Market - Regional Segment Analysis
    • 8.1. Global Pharmacovigilance and Drug Safety Software Market: Regional overview
      • 8.1.1. Global Pharmacovigilance and Drug Safety Software Market revenue share, by region, 2017 and 2025
    • 8.2. North America
      • 8.2.1. North America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.2.2. North America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.2.3. North America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.2.4.2. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.2.4.3. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.2.5.2. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.2.5.3. Canada Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.3.2. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.3.3. Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.4.2. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.4.3. Germany Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.5. France
        • 8.3.5.1. France Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.5.2. France Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.5.3. France Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.6. UK
        • 8.3.6.1. UK Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.6.2. UK Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.6.3. UK Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.3.7.2. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.3.7.3. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.4.2. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.4.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.4.2. China Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.4.3. China Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.5.2. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.5.3. Japan Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.6.2. India Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.6.3. India Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.5.2. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.5.3. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.5.4.2. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.5.4.3. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017-2025 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Oracle Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. ArisGlobal LLC
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. AB Cube
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Max Delivery
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Relsys
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Sparta Systems, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. United BioSource Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. EXTEDO GmbH
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Ennov Solutions, Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Umbra Global
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Therapy portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Pharmacovigilance and Drug Safety Software Market revenue, 2017–2025 (USD Million)
4. Porter’s Five Forces analysis
5. Pharmacovigilance and Drug Safety Software Market by Functionality 
6. Pharmacovigilance and Drug Safety Software by Delivery Mode
7. Pharmacovigilance and Drug Safety Software by end-user
8. Pharmacovigilance and Drug Safety Software by region
9. Company market share analysis, 2018
10. Global Pharmacovigilance and Drug Safety Software Market revenue share by Functionality, 2017 and 2025
11. Global ADR Reporting Software Market, 2017–2025 (USD Million)
12. Global Drug Safety Audits Software market, 2017–2025 (USD Million)
13. Global Issue Tracking Software market, 2017–2025 (USD Million)
14. Global Fully Integrated Software market, 2017–2025 (USD Million)
15. Global Pharmacovigilance and Drug Safety Software Market revenue share by Delivery Mode, 2017 and 2025
16. Global Pharmacovigilance and Drug Safety Software Market for On-premises, 2017–2025 (USD Million)
17. Global Pharmacovigilance and Drug Safety Software Market for On-demand, 2017–2025 (USD Million)
18. Global Pharmacovigilance and Drug Safety Software Market revenue share by end-user, 2017 and 2025
19. Global Pharmacovigilance and Drug Safety Software Market for pharma and biotech companies, 2017–2025 (USD Million)
20. Global Pharmacovigilance and Drug Safety Software Market for Contract Research Organizations, 2017–2025 (USD Million)
21. Global Pharmacovigilance and Drug Safety Software Market for Business Process Outsourcing, 2017–2025 (USD Million)
22. Global Pharmacovigilance and Drug Safety Software Market for Other Pharmacovigilance Service Providers, 2017–2025 (USD Million)


Table Of Tables

List of Tables

1. Pharmacovigilance and Drug Safety Software Market: Market Snapshot                                                                                    
2. Drivers of global Pharmacovigilance and Drug Safety Software Market: Impact analysis 
3. Restraints of global Pharmacovigilance and Drug Safety Software Market: Impact analysis  
4. North America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
5. North America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
6. North America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million) 
7. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
8. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
9. The U.S. Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
10. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
11. Canada Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
12. Canada Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
13. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
14. Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
15. Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
16. UK Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
17. UK Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
18. UK Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
19. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
20. Germany Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
21. Germany Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
22. France Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
23. France Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
24. France Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
25. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
26. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
27. Rest of Europe Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
28. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
29. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
30. Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
31. China Pharmacovigilance and Drug Safety Software Market revenue, by Functionality2017–2025 (USD Million) 
32. China Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode2017–2025 (USD Million) 
33. China Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
34. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
35. Japan Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
36. Japan Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
37. India Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
38. India Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
39. India Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
40. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
41. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
42. Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
43. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
44. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
45. Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
46. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
47. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
48. Brazil Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
49. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million) 
50. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million) 
51. Rest of Latin America Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)
52. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Functionality, 2017–2025 (USD Million)
53. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by Delivery Mode, 2017–2025 (USD Million)
54. The Middle East and Africa Pharmacovigilance and Drug Safety Software Market revenue, by end-user, 2017–2025 (USD Million)

Methodology

FrequentlyAsked Questions

Pharmacovigilance and drug safety software or tools aid in classifying, reviewing, and forming pharmacovigilance data. This software also helps in the formation of repots related to adverse medical events.

According to study, the Pharmacovigilance and Drug Safety Software Market size was worth around USD 200.5 million in 2023 and is predicted to grow to around USD 370.48 million by 2032.

The CAGR value of Pharmacovigilance and Drug Safety Software Market is expected to be around 7.06% during 2024-2032.

North America has been leading the Pharmacovigilance and Drug Safety Software Market and is anticipated to continue on the dominant position in the years to come.

The Pharmacovigilance and Drug Safety Software Market is led by players like Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems Inc., United BioSource Corporation, EXTEDO GmbH, Ennov Solutions Inc., and among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed